Metformin with standard therapy shows no significant survival benefit in gynecologic cancers
Does adding metformin to cancer treatment help women with gynecologic cancers?
A meta-analysis of 5 RCTs involving 705 patients with gynecologic malignancies found metformin combined with standard therapy did not signif…
Adding the diabetes drug metformin to standard cancer treatment did not help women with gynecologic cancers live longer or delay disease pro…
